Business Context and Reporting Period
This Form 8-K Current Report was filed by REED's, INC. on February 6, 2023. The report discloses the appointment of a new executive officer effective February 1, 2023.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on personnel changes and associated compensation.
Material Changes
The primary material change is the appointment of Christopher Burleson as Chief Commercial Officer. In this role, Mr. Burleson will lead the sales organization, partner with operations to streamline supply chain and cost reduction initiatives, and focus on strategic partnerships.
Management Commentary and Compensation Details
- Compensation Package: Mr. Burleson receives an annual salary of $300,000.
- Bonus: Eligible for an annual performance bonus with a target of 35% of his annual salary.
- Equity Grant: Received a vested Restricted Stock Award (RSA) of approximately 18,160 shares valued at $75,000 as an inducement to accept the position.
- Benefits: Eligible for 4 weeks of paid vacation, participation in the incentive stock option program, an $800 car allowance, and a $150 allowance for cell phone and internet costs. He is not eligible for health insurance benefits.
- Background: Previously served as Chief Commercial Officer of Kin Social Tonics (2022-2023) and Vice President/General Manager of Fever Tree, USA (2018-2022).
Investor Verification Checklist
- Verify the impact of the new Chief Commercial Officer on sales growth and supply chain efficiency in upcoming quarterly reports.
- Confirm the vesting status and valuation of the 18,160 share RSA grant in subsequent equity filings.
- Monitor for any changes in the company's cost structure resulting from the new officer's initiatives.